EP 0505901 B1 19960619 - Use of 1-phenoxycarbonyl-2-pyrralidinone derivatives for treating or preventing platelet aggregation
Title (en)
Use of 1-phenoxycarbonyl-2-pyrralidinone derivatives for treating or preventing platelet aggregation
Title (de)
Verwendung von 1-Phenoxycarbonyl-2-pyrrolidinonderivaten zur Behandlung oder Verhütung der Blutplättchenaggregation
Title (fr)
Utilisation de dérivés de la 1-phénoxycarbonyle-2-pyrrolidinone pour le traitement ou la prévention de l'agrégation plaquettaire
Publication
Application
Priority
JP 8304891 A 19910325
Abstract (en)
[origin: EP0505901A2] Use of a compound of the formula <CHEM> wherein R is a C1-C6 alkyl group, a C1-C6 alkoxy group, a nitro group or a halogen atom and n is 0, 1 or 2, for the manufacture of a medicament for treating or preventing a platelet aggregation in a mammal.
IPC 1-7
IPC 8 full level
A61K 31/40 (2006.01); A61K 31/4015 (2006.01); A61P 7/02 (2006.01); C07D 207/27 (2006.01)
CPC (source: EP US)
A61K 31/40 (2013.01 - EP US); A61P 7/02 (2017.12 - EP)
Designated contracting state (EPC)
DE FR GB
DOCDB simple family (publication)
EP 0505901 A2 19920930; EP 0505901 A3 19930113; EP 0505901 B1 19960619; CA 2063773 A1 19920926; DE 69211588 D1 19960725; DE 69211588 T2 19961010; JP 3038032 B2 20000508; JP H04295426 A 19921020; US 5227395 A 19930713
DOCDB simple family (application)
EP 92104634 A 19920318; CA 2063773 A 19920323; DE 69211588 T 19920318; JP 8304891 A 19910325; US 85490492 A 19920320